Zentek Ltd. (NASDAQ:ZTEK) Sees Significant Growth in Short Interest

Zentek Ltd. (NASDAQ:ZTEK) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 156,100 shares, a growth of 79.8% from the August 31st total of 86,800 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average trading volume of 289,800 shares, the short-interest ratio is currently 0.5 days. Based on an average trading volume of 289,800 shares, the short-interest ratio is currently 0.5 days. Approximately 0.2% of the company’s shares are short sold.

Zentek Stock Down 1.0%

Shares of Zentek stock opened at $0.78 on Friday. The stock’s fifty day moving average is $0.83 and its 200-day moving average is $1.12. Zentek has a 12-month low of $0.50 and a 12-month high of $1.84. The company has a quick ratio of 1.30, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $81.69 million, a PE ratio of -15.60 and a beta of 0.90.

Zentek (NASDAQ:ZTEK) last issued its earnings results on Thursday, August 14th. The company reported ($0.01) EPS for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 55.41%. The firm had revenue of $0.04 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Zentek in a report on Saturday, September 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Zentek presently has an average rating of “Sell”.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.